Your activity: 20 p.v.
your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com

Modified World Health Organization classification of cardiovascular disease in pregnancy

Modified World Health Organization classification of cardiovascular disease in pregnancy
Risk classification Cardiac lesions

Class I

No detectable increased risk of maternal mortality and no or minimal increase in maternal morbidity
  • Uncomplicated mild pulmonary stenosis
  • Ventricular septal defect
  • Patent ductus arteriosus
  • Mitral valve prolapse with no more than trivial mitral regurgitation
  • Successfully repaired simple lesions (atrial or ventricular septal defect, patent ductus arteriosus, anomalous pulmonary venous drainage)
  • Isolated ventricular extra-systoles and atrial ectopic beats

Class II

Small increased risk of maternal mortality or moderate increase in morbidity
  • Unoperated atrial or ventricular septal defect
  • Repaired tetralogy of Fallot
  • Most arrhythmias

Class II-III

Some increased risk depending on patient
  • Hypertrophic cardiomyopathy
  • Native or tissue valvular heart disease not considered mWHO I or IV
  • Repaired coarctation
  • Marfan syndrome without aortic dilatation
  • Bicuspid valve with aorta <45 mm
  • Mild ventricular impairment
  • Heart transplantation

Class III

Significantly increased risk of maternal mortality or severe morbidity
  • Mechanical valve
  • Systemic right ventricle
  • Fontan circulation
  • Unrepaired cyanotic heart disease
  • Other complex congenital heart disease
  • Marfan syndrome with aorta 40 to 45 mm
  • Bicuspid aortic valve with aorta 45 to 50 mm

Class IV

Pregnancy is contraindicated
  • Pulmonary hypertension
  • Eisenmenger syndrome
  • Systemic ventricular EF <30%
  • Systemic ventricular dysfunction with NYHA class III-IV
  • Severe mitral stenosis or symptomatic aortic stenosis
  • Marfan syndrome with aorta >45 mm
  • Bicuspid aortic valve with aorta >50 mm
  • Native severe coarctation
  • Prior peripartum cardiomyopathy with any residual impairment of ventricular function
mWHO: modified World Health Organization; EF: ejection fraction; NYHA: New York Heart Association.
From: Meng ML, Arendt KW. Obstetric Anesthesia and Heart Disease: Practical Clinical Considerations. Anesthesiology 2021; 135:164. DOI: 10.1097/ALN.0000000000003833. Copyright © 2021 American Society of Anesthesiologists. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.
Graphic 134079 Version 1.0